Home
BCTX
BCTX News

Latest BriaCell Therapeutics Corp. (BCTX) News on November 22, 2024

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

GlobeNewswire

16 hours ago

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

GlobeNewswire

14 days ago

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

GlobeNewswire

18 days ago

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

MT Newswires

a month ago

BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

GlobeNewswire

a month ago

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

MT Newswires

a month ago

BriaCell to Complete Patient Enrollment for Phase 3 Breast Cancer Study by Mid-2025; Shares Rise

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

GlobeNewswire

a month ago

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

MT Newswires

2 months ago

BriaCell Therapeutics Closes Offering of 5.13 Million Shares, Warrants

BriaCell Therapeutics Announces Closing of $5 Million Offering

GlobeNewswire

2 months ago

BriaCell Therapeutics Announces Closing of $5 Million Offering

MT Newswires

2 months ago

BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

MT Newswires

2 months ago

BriaCell Therapeutics Down 41% as it Announces US$5-Million Share-Unit Offering

BriaCell Therapeutics Announces $5 Million Offering

GlobeNewswire

2 months ago

BriaCell Therapeutics Announces $5 Million Offering

MT Newswires

2 months ago

BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

GlobeNewswire

2 months ago

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

Zacks

2 months ago

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

MT Newswires

2 months ago

BriaCell Says FDA Greenlit Expanded Access Policy for Metastatic Breast Cancer Patients

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

GlobeNewswire

2 months ago

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

MT Newswires

2 months ago

BriaCell Therapeutics Closes $8.5 Million Offering

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

GlobeNewswire

2 months ago

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

MT Newswires

2 months ago

BriaCell Therapeutics Announces US$8.5 Million Share Offering

MT Newswires

2 months ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires

2 months ago

BriaCell Therapeutics Prices $8.5 Million Offering

BriaCell Therapeutics Announces $8.5 Million Offering

GlobeNewswire

2 months ago

BriaCell Therapeutics Announces $8.5 Million Offering

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

Benzinga

2 months ago

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

MT Newswires

2 months ago

Update: BriaCell Shares Surge After Reporting Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study

MT Newswires

2 months ago

Sector Update: Health Care Stocks Narrowly Mixed Premarket Wednesday

MT Newswires

2 months ago

BriaCell Reports Longer Overall Survival Rate in Phase 2 Breast Cancer Study

MT Newswires

2 months ago

BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

GlobeNewswire

2 months ago

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

MT Newswires

2 months ago

BriaCell Receives Positive Feedback From FDA Meeting Over Potential Prostate Cancer Drug

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

GlobeNewswire

2 months ago

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire

2 months ago

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

GlobeNewswire

4 months ago

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

BriaCell Presents Clinical Efficacy Data at ASCO 2024

GlobeNewswire

6 months ago

BriaCell Presents Clinical Efficacy Data at ASCO 2024

MT Newswires

6 months ago

BriaCell Begins Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer

GlobeNewswire

6 months ago

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer

MT Newswires

6 months ago

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study

MT Newswires

6 months ago

BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

GlobeNewswire

6 months ago

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year

Simply Wall St.

6 months ago

This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year

MT Newswires

6 months ago

Briacell Therapeutics Insider Bought Shares Worth $2,000,001, According to a Recent SEC Filing

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

GlobeNewswire

6 months ago

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

MT Newswires

6 months ago

BriaCell Therapeutics Prices $5 Million Offering; Shares Tumble

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

GlobeNewswire

6 months ago

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

MT Newswires

7 months ago

BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting

BriaCell Announces Oral and Poster Presentations at ASCO 2024

GlobeNewswire

7 months ago

BriaCell Announces Oral and Poster Presentations at ASCO 2024

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

GlobeNewswire

7 months ago

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

GlobeNewswire

7 months ago

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

GlobeNewswire

9 months ago

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

GlobeNewswire

9 months ago

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

GlobeNewswire

9 months ago

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

Get Rich Quick With These 3 Penny Stocks to Buy Now

InvestorPlace

9 months ago

Get Rich Quick With These 3 Penny Stocks to Buy Now

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

GlobeNewswire

9 months ago

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

GlobeNewswire

10 months ago

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

Stock Market Today: Nasdaq Drops Then Pops After Strong Jobs Report; Big Winners Include Meta, Amazon, Deckers

Investor's Business Daily

10 months ago

Stock Market Today: Nasdaq Drops Then Pops After Strong Jobs Report; Big Winners Include Meta, Amazon, Deckers

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire

10 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

FAT Brands Foundation Awards Over $250,000 to Local Non-Profits in 2023

GlobeNewswire

10 months ago

FAT Brands Foundation Awards Over $250,000 to Local Non-Profits in 2023

LiveOne (Nasdaq: LVO) Launches "Splitmind Radio" Exclusively on Slacker Radio

NewMediaWire

10 months ago

LiveOne (Nasdaq: LVO) Launches "Splitmind Radio" Exclusively on Slacker Radio

Is Five Point Holdings (FPH) Well Positioned for Success in 2024 and Beyond?

Insider Monkey

10 months ago

Is Five Point Holdings (FPH) Well Positioned for Success in 2024 and Beyond?

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

InvestorPlace

10 months ago

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

OP Bancorp Reports Steady Earnings Amidst Economic Headwinds

GuruFocus.com

10 months ago

OP Bancorp Reports Steady Earnings Amidst Economic Headwinds

3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom

InvestorPlace

10 months ago

3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom

FAT Brands (FAT) Reports Solid Unit Developments in 2023

Zacks

10 months ago

FAT Brands (FAT) Reports Solid Unit Developments in 2023

SYLA Technologies Became the Largest Shareholder of RIBERESUTE by Acquiring 20.39% of its Shares

GlobeNewswire

10 months ago

SYLA Technologies Became the Largest Shareholder of RIBERESUTE by Acquiring 20.39% of its Shares

Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength?

Zacks

10 months ago

Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength?

NN, Inc. Reports Record-Breaking $62.6 Million of New Business Wins in 2023

GlobeNewswire

10 months ago

NN, Inc. Reports Record-Breaking $62.6 Million of New Business Wins in 2023

ReposiTrak Traceability Network Continues Rapid Growth with 3 New Produce Suppliers Including Indoor Grower, Ripening Operation and Large-scale Producer/Distributor

Business Wire

10 months ago

ReposiTrak Traceability Network Continues Rapid Growth with 3 New Produce Suppliers Including Indoor Grower, Ripening Operation and Large-scale Producer/Distributor

5 Solid Stocks to Buy on a Solid Jump in Factory Orders

Zacks

10 months ago

5 Solid Stocks to Buy on a Solid Jump in Factory Orders

Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives

PR Newswire

10 months ago

Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones

GlobeNewswire

a year ago

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

Here's Why You Should Invest in Adverum (ADVM) Stock Now

Zacks

a year ago

Here's Why You Should Invest in Adverum (ADVM) Stock Now

Li-Cycle Receives Continued Listing Standard Notice from NYSE

Business Wire

a year ago

Li-Cycle Receives Continued Listing Standard Notice from NYSE

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

GlobeNewswire

a year ago

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

Xiao-I Corporation's (NASDAQ:AIXI) largest shareholders are retail investors with 49% ownership, insiders own 29%

Simply Wall St.

a year ago

Xiao-I Corporation's (NASDAQ:AIXI) largest shareholders are retail investors with 49% ownership, insiders own 29%

Femco Steel Technology Co., Ltd. to be Publicly Listed in the U.S. Through a Business Combination with Chenghe Acquisition I Co.

PR Newswire

a year ago

Femco Steel Technology Co., Ltd. to be Publicly Listed in the U.S. Through a Business Combination with Chenghe Acquisition I Co.

$BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset$

GlobeNewswire

a year ago

BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset

Burning Rock Announces Results of 2023 Annual General Meeting

GlobeNewswire

a year ago

Burning Rock Announces Results of 2023 Annual General Meeting

Zacks Small Cap Research

a year ago

BCTX: Down in San Antone

GlobeNewswire

a year ago

Diamond Equity Research Releases Update Note on QuantaSing Group Limited (NASDAQ: QSG)

A Closer Look At QuantaSing Group Limited's (NASDAQ:QSG) Impressive ROE

Simply Wall St.

a year ago

A Closer Look At QuantaSing Group Limited's (NASDAQ:QSG) Impressive ROE

Eos Energy Announces Pricing of $50 Million Public Offering

GlobeNewswire

a year ago

Eos Energy Announces Pricing of $50 Million Public Offering

Insider Sell Alert: President and CEO HULL THOMAS DAVID III Sells 6,000 Shares of Kewaunee ...

GuruFocus.com

a year ago

Insider Sell Alert: President and CEO HULL THOMAS DAVID III Sells 6,000 Shares of Kewaunee ...

Eos Energy Announces Launch of Proposed $40M Public Offering

GlobeNewswire

a year ago

Eos Energy Announces Launch of Proposed $40M Public Offering

Seanergy Maritime Holdings (NASDAQ:SHIP) Has Announced A Dividend Of $0.025

Simply Wall St.

a year ago

Seanergy Maritime Holdings (NASDAQ:SHIP) Has Announced A Dividend Of $0.025

Here's Why We Think Oak Valley Bancorp (NASDAQ:OVLY) Is Well Worth Watching

Simply Wall St.

a year ago

Here's Why We Think Oak Valley Bancorp (NASDAQ:OVLY) Is Well Worth Watching

Kewaunee Scientific Corporation's (NASDAQ:KEQU) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.

a year ago

Kewaunee Scientific Corporation's (NASDAQ:KEQU) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Li-Cycle Comments on Process to Evaluate Financing and Strategic Alternatives

Business Wire

a year ago

Li-Cycle Comments on Process to Evaluate Financing and Strategic Alternatives

Eltek (NASDAQ:ELTK) Could Be A Buy For Its Upcoming Dividend

Simply Wall St.

a year ago

Eltek (NASDAQ:ELTK) Could Be A Buy For Its Upcoming Dividend

BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS

GlobeNewswire

a year ago

BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS

BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit

GlobeNewswire

a year ago

BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit

Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

Insider Sell: Director Rex Davidson Sells 4,980 Shares of Acme United Corp (ACU)

GuruFocus.com

a year ago

Insider Sell: Director Rex Davidson Sells 4,980 Shares of Acme United Corp (ACU)

Risk and Reward: 3 Bank Stocks for the Bold Investor

InvestorPlace

a year ago

Risk and Reward: 3 Bank Stocks for the Bold Investor

The past five years for Primis Financial (NASDAQ:FRST) investors has not been profitable

Simply Wall St.

a year ago

The past five years for Primis Financial (NASDAQ:FRST) investors has not been profitable

Saga Communications (NASDAQ:SGA) investors are sitting on a loss of 21% if they invested five years ago

Simply Wall St.

a year ago

Saga Communications (NASDAQ:SGA) investors are sitting on a loss of 21% if they invested five years ago

Need To Know: The Consensus Just Cut Its Seer, Inc. (NASDAQ:SEER) Estimates For 2024

Simply Wall St.

a year ago

Need To Know: The Consensus Just Cut Its Seer, Inc. (NASDAQ:SEER) Estimates For 2024

Newly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen®, Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) Patients

Business Wire

a year ago

Newly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen®, Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) Patients

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Insider Monkey

a year ago

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Share on Social Networks: